Budesonide nebulizing solution (Pulmicort Respules): Uses, Side Effects, Alternatives & More - GoodRx
![Global Budesonide Inhaler Market by Products Type (Inhalants, Nebulizers), Dosage (Aerosols, Dry Powder, Spray), Distribution Channel - Forecast 2024-2030 Global Budesonide Inhaler Market by Products Type (Inhalants, Nebulizers), Dosage (Aerosols, Dry Powder, Spray), Distribution Channel - Forecast 2024-2030](http://www.researchandmarkets.com/product_images/11389/11389096_500px_jpg/global_budesonide_inhaler_market.jpg)
Global Budesonide Inhaler Market by Products Type (Inhalants, Nebulizers), Dosage (Aerosols, Dry Powder, Spray), Distribution Channel - Forecast 2024-2030
![Budesonide Controlled Release Tablets 9mg BUDOCOL-TABLET at Rs 3900/box | Budecort Inhaler in Bengaluru | ID: 2853237300297 Budesonide Controlled Release Tablets 9mg BUDOCOL-TABLET at Rs 3900/box | Budecort Inhaler in Bengaluru | ID: 2853237300297](http://5.imimg.com/data5/SELLER/Default/2024/1/376950747/SO/NB/DZ/3234517/bi-500x500.jpg)
Budesonide Controlled Release Tablets 9mg BUDOCOL-TABLET at Rs 3900/box | Budecort Inhaler in Bengaluru | ID: 2853237300297
![Post discharge use of nebulized pulmicort respules® in children after an emergency department visit or hospitalization for an asthma exacerbation | PPT Post discharge use of nebulized pulmicort respules® in children after an emergency department visit or hospitalization for an asthma exacerbation | PPT](https://image.slidesharecdn.com/post-dischargeuseofnebulizedpulmicortrespulesinchildrenafteranemergencydepartmentvisitorhospitalizat-140909072652-phpapp01/85/post-discharge-use-of-nebulized-pulmicort-respules-in-children-after-an-emergency-department-visit-or-hospitalization-for-an-asthma-exacerbation-40-320.jpg?cb=1667475924)
Post discharge use of nebulized pulmicort respules® in children after an emergency department visit or hospitalization for an asthma exacerbation | PPT
![Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/c8a53fd8-7246-40de-acd7-9d497f8dee0c/gr1_lrg.gif)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
![Levosalbutamol 1.25 mg Budesonide IP 0.5 mg INTRACORT-L RESPULES at Rs 840/piece | PULMOLIFE in Bengaluru | ID: 2851723508655 Levosalbutamol 1.25 mg Budesonide IP 0.5 mg INTRACORT-L RESPULES at Rs 840/piece | PULMOLIFE in Bengaluru | ID: 2851723508655](http://5.imimg.com/data5/SELLER/Default/2023/7/323268908/NA/NE/CH/3234517/levosalbutamol-1-25-mg-budesonide-ip-0-5-mg-intracort-l-respules-500x500.jpg)
Levosalbutamol 1.25 mg Budesonide IP 0.5 mg INTRACORT-L RESPULES at Rs 840/piece | PULMOLIFE in Bengaluru | ID: 2851723508655
![Nebulized Inhaled Corticosteroids in Asthma Treatment in Children 5 Years or Younger: A Systematic Review and Global Expert Analysis - The Journal of Allergy and Clinical Immunology: In Practice Nebulized Inhaled Corticosteroids in Asthma Treatment in Children 5 Years or Younger: A Systematic Review and Global Expert Analysis - The Journal of Allergy and Clinical Immunology: In Practice](https://www.jaci-inpractice.org/cms/asset/d9626dac-f4eb-41d8-a3f7-e3d487094850/gr2b.jpg)